BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Melanoma Institute Australia - ECPv6.17.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://melanoma.org.au
X-WR-CALDESC:Events for Melanoma Institute Australia
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Australia/Sydney
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20250405T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20251004T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20260404T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20261003T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20270403T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20271002T160000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260819T170000
DTEND;TZID=Australia/Sydney:20260819T170000
DTSTAMP:20260505T060732Z
CREATED:20260505T060732Z
LAST-MODIFIED:20260505T060732Z
UID:10000293-1787158800-1787158800@melanoma.org.au
SUMMARY:MRFF Genomics Health Futures
DESCRIPTION:The objective of this grant opportunity is to provide grants of financial assistance to support medical research and medical innovation projects that: \nStream 1 (TCR): develop genomic tools and technologies to identify genetic predisposition to cancer and improve screening and targeted intervention. Focus on increased access to genomic testing and on liquid biopsy. \nStream 2 (TCR): conduct scalable research to enhance novel gene discoveries\, increase diagnostic rates and enable disease modelling to support development of targeted therapies or prevention strategies. \nStream 3 (Incubator): develop novel methods for using polygenic risk scores to identify subgroups of the population at high risk of common and complex diseases (cardiovascular disease\, diabetes and other common and/or complex diseases). \nStream 4 (Incubator): develop novel methods for improving accuracy and usefulness of polygenic risk scores to stratify people with common cancers for surveillance and treatment (breast cancer\, colorectal cancer\, prostate cancer and other common cancers) \nStream 5 (TCR): undertake research to enhance or streamline uptake of clinical genomics into practice. \nStream 6 (Accelerator): develop and maintain infrastructure to support research collaboration by enabling data sharing\, portability\, longevity and connectivity of analysis across Australia. Research conducted should address emerging ethical\, legal and social issues associated with the governance of clinical and genomic datasets with particular focus on the application of advanced analytics (e.g. AI) to enhance the diagnostic utility of genomics. \nApplicants must propose research that addresses these objectives and those of the Genomics Health Futures Mission as outlined in the Roadmap and Implementation Plan. \nKey Dates \n\nMinimum data due date: 22 July 2026\nApplications close: 19 August 2026\nIndicative funding status: Funding anticipated to be awarded from June 2027 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/mrff-genomics-health-futures/
CATEGORIES:Grants,Industry
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/05/MRFF-Genomics-Health-Futures600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260819T170000
DTEND;TZID=Australia/Sydney:20260819T170000
DTSTAMP:20260602T045536Z
CREATED:20260602T045536Z
LAST-MODIFIED:20260602T045536Z
UID:10000303-1787158800-1787158800@melanoma.org.au
SUMMARY:MRFF EMCR Initiative - Early to Mid-Career Researchers Grant
DESCRIPTION:The Medical Research Future Fund (MRFF) –2026 Early to Mid-Career Researchers Grant Opportunity will support research to build and grow research capacity and capability in Australia by supporting Early to Mid-Career Researchers (EMCRs) to continue their health and medical research careers. \nThe objective of this grant opportunity is to provide grants of financial assistance to support medical research and medical innovation projects that: \n\nStream 1 (Incubator): conduct early stage\, small scale research\, led by early career researchers\, that seeks to assess the potential and feasibility of novel strategies to address a critical or intractable health issue in one or more Priority Populations.\nStream 2 (Accelerator): establish a large-scale interdisciplinary research program\, led by mid-career researchers\, that drives implementation of substantial improvements to health care and/or health system effectiveness for one or more Priority Populations.\nStream 3 (Targeted Call for Research): utilise co-funding to accelerate the translation of research led by early or mid-career researchers into policy and practice. (Note: a priority population focus is not required).\n\nThe intended outcome of the research is to improve the health and wellbeing of Australians by: \n\nStream 1 (Incubator): supporting early career researchers to develop innovative solutions for addressing significant health challenges in Priority Populations.\nStream 2 (Accelerator): supporting mid-career researchers to transform health practice and/or policy for Priority Populations.\nStream 3 (Targeted Call for Research): supporting early to mid-career researchers to translate new health solutions into practice.\n\n\nKey Dates:\nMinimum data due: 22 July 2026\nApplications close: 19 August 2026\nGrant activity timeframe: February 2027 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/mrff-emcr-initiative/
CATEGORIES:Grants,Early to Mid Career Researcher
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/06/MRFF-EMCR-Initiative-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260923T170000
DTEND;TZID=Australia/Sydney:20260923T170000
DTSTAMP:20260804T062200Z
CREATED:20260804T054543Z
LAST-MODIFIED:20260804T062200Z
UID:10000322-1790182800-1790182800@melanoma.org.au
SUMMARY:NHMRC Equipment Grants
DESCRIPTION:The objectives of Equipment Grants are to support Administering Institutions to: \n• be strategic in the purchase of larger items of equipment that will benefit health and medical research in Australia; \n• purchase equipment that will be used collaboratively; \n• where possible\, purchase Australian-made equipment; and \n• provide ongoing service\, upgrades\, maintenance and repair costs for equipment used on NHMRC funded Research Activities. \nThe 2026 Equipment grant opportunity is a Demand Driven (eligibility-based) process. Applications are automatically generated by NHMRC’s granting system. \n\nKey Dates:\nApplications close: 23 September 2026 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/nhmrc-equipment-grants/
CATEGORIES:Grants,Infrastructure & Equipment
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/07/NHMRC_Equipment_Grants-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260923T170000
DTEND;TZID=Australia/Sydney:20260923T170000
DTSTAMP:20260804T062111Z
CREATED:20260804T054722Z
LAST-MODIFIED:20260804T062111Z
UID:10000321-1790182800-1790182800@melanoma.org.au
SUMMARY:NHMRC Independent Research Institutes Infrastructure Support Scheme
DESCRIPTION:IRIISS allocates funds for infrastructure support to independent medical research institutes managing NHMRC research funds. \nIRIISS aims to develop and maintain infrastructure to support high quality health and medical research by contributing to infrastructure costs associated with competitively awarded NHMRC research grants managed by independent medical research institutes. \nThe 2026 Independent Research Institutes Infrastructure Support Scheme grant opportunity is a Demand Driven (eligibility-based) process. \n\nKey Dates:\nApplications close: 23 September 2026 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/nhmrc-iriiss/
CATEGORIES:Grants,Infrastructure & Equipment
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/07/NHMRC_IRIISS-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20261104T170000
DTEND;TZID=Australia/Sydney:20261104T170000
DTSTAMP:20260804T062313Z
CREATED:20260804T054341Z
LAST-MODIFIED:20260804T062313Z
UID:10000323-1793811600-1793811600@melanoma.org.au
SUMMARY:NHMRC Clinical Trials and Cohort Studies Grants
DESCRIPTION:Clinical Trials and Cohort Studies Grants support high-quality clinical trials and cohort studies that address important gaps in knowledge\, leading to relevant and implementable findings for the benefit of human health. \nThis funding scheme is open to research proposals for clinical trials and/or cohort studies of any size – that is\, they may be large or small clinical trials or cohort studies. \nThe intended outcomes of the Clinical Trials and Cohort Studies Grants scheme are improvements in health and well-being\, health care practice or policy\, as a result of: \n\nHigh-quality clinical trials that provide reliable evidence of the effects of health-related interventions on health outcomes (or appropriate surrogates).\nHigh-quality cohort studies that provide reliable evidence on the relation of important risk factors and other exposures to health-related outcomes.\nHigh quality retrospective cohort studies that provide reliable evidence on the relation of important risk factors and other exposures to health-related outcomes.\n\n\nKey Dates:\nApplications open: 9 September 2026\nMinimum data due date: 7 October 2026\nApplications close: 4 November 2026 \nGuidelines will be available when the grant opens. \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/nhmrc-clinical-trials-grants/
CATEGORIES:Grants,Clinical Trial Cohorts
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/07/NHMRC_Clinical_Trials_Grants-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20261111T170000
DTEND;TZID=Australia/Sydney:20261111T170000
DTSTAMP:20260331T013110Z
CREATED:20260331T013110Z
LAST-MODIFIED:20260331T013110Z
UID:10000276-1794416400-1794416400@melanoma.org.au
SUMMARY:NHMRC Partnership Projects
DESCRIPTION:The Partnership Project funding scheme provides funding and support to create new opportunities for researchers and policy makers to work together to define research questions\, undertake research\, interpret the findings and implement the findings into policy and practice. \n\nPartnership Projects create partnerships among decision makers\, policy makers\, managers\, clinicians and researchers and answer a specific research question to influence health and wellbeing through changes in the delivery\, organisation\, funding and access to health services. \nPartnership Projects will support collaborations\, within the Australian context\, that translate research evidence into health policy and health practice\, to improve health services and processes. \nThe objectives of the Partnership Project scheme are to: \n• Meet the need for more effective integration of research evidence into health policy and service delivery\n• Create partnerships among policy makers\, managers\, service providers and researchers\n• Provide support to answer often complex and difficult questions that policy makers\, managers and service providers face when making decisions and implementing policies that affect Australians’ health and health care\n• Be highly responsive to the priorities of government\, the community and health professionals\n• Enable applicants to apply for funding at any time during the year to allow researchers and Partner Organisations to develop timely collaborations. \n\nKey Dates for Peer Review Cycle 2:\nApplications open: 19 March 2026\nNHMRC-approved Administering Institutions waiver due: 8 July 2026\nMinimum data due: 22 July 2026\nApplications close: 5 August 2026\nPeer review meetings: 17-19 November 2026 \nKey Dates for Peer Review Cycle 3:\nApplications open: 23 July 2026\nNHMRC-approved Administering Institutions waiver due: 14 October 2026\nMinimum data due: 28 October 2026\nApplications close: 11 November 2026\nPeer review meetings: 2-4 March 2027 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/nhmrc-partnership-projects/
CATEGORIES:Grants,Industry
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/03/NHMRC-Partnership-600-x-338-px.jpg
END:VEVENT
END:VCALENDAR